Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Amanda I. Silverio, Matthew C. Squires and Julia C. Knight
Substance use Disorder (SUD) is a common disorder in the United States and is frequently comorbid with depression. Electroconvulsive therapy (ECT) is the most effective treatment for depression. However, literature offers an unclear picture of whether patients with comorbid SUD are less likely to receive, or benefit from, ECT. Limited data exists regarding alcohol use disorder in ECT, while the impact of other types of SUD in ECT patients remains mostly unexplored. In this article, we review the current literature base for SUD in ECT patients and present a case where ECT was used successfully in a patient with bipolar affective disorder, current episode depressed, as well as co-morbid alcohol use disorder and opioid use disorder, in sustained remission on medication assisted therapy. Further research into ECT utilization patterns and response rates for patients with opioid use disorder is indicated.